Income Statement atect corporation

Stocks

4241

JP3121300002

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange 07:30:00 11/09/2026 BST			5-day change	1st Jan Change
645.00 ^JPY	-1.53%		-1.07%	+21.01%

b33cedcc07357e0c9c024f9ffbdb3.vI1RP00jBA0m0ORiGux_1kGCu8sqvWvtF5ekMXkQK5Y.190HYBtGQEh2pYZaT9QPiQfU8PhMzTKUcvrKaB9jcuyF9BNQKBpPSGLklw

Published financial data: ATECT CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022 (JPY)	2023 (JPY)	2024 (JPY)	2025 (JPY)	2026 (JPY)
Revenues	3.09B	2.96B	3.18B	3.2B	3.36B
Total Revenues	3.09B	2.96B	3.18B	3.2B	3.36B
Cost of Goods Sold, Total	1.51B	1.59B	1.8B	1.91B	2.02B
Gross Profit	1.58B	1.37B	1.38B	1.29B	1.33B
Selling General & Admin Expenses, Total	1.06B	1.02B	1.17B	1.2B	1.12B
Provision for Bad Debts	-	-	-	1M	-
R&D Expenses	196M	169M	140M	4M	2M
Depreciation & Amortization - (IS)	12M	13M	-	-	-
Other Operating Expenses, Total	1.26B	1.21B	1.31B	1.21B	1.13B
Operating Income	312M	163M	64M	81M	205M
Interest Expense, Total	-17M	-15M	-13M	-14M	-18M
Interest And Investment Income	-	1M	5M	4M	5M
Net Interest Expenses	-17M	-14M	-8M	-10M	-13M
Currency Exchange Gains (Loss)	7M	1M	13M	-9M	5M
Other Non Operating Income (Expenses)	46M	42M	10M	3M	11M
EBT, Excl. Unusual Items	348M	192M	79M	65M	208M
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	1M	-	-	-	20M
Asset Writedown	-144M	-4M	-429M	-	-
Other Unusual Items	49M	9M	-	-	-
EBT, Incl. Unusual Items	254M	197M	-350M	65M	228M
Income Tax Expense	85M	39M	-106M	25M	87M
Earnings From Continuing Operations	169M	158M	-244M	40M	141M
Net Income to Company	169M	158M	-244M	40M	141M
Net Income - (IS)	169M	158M	-244M	40M	141M
Net Income to Common Incl Extra Items	169M	158M	-244M	40M	141M
Net Income to Common Excl. Extra Items	169M	158M	-244M	40M	141M
Per Share Items
Net EPS - Basic	38.26	35.74	-55.19	9.05	31.89
Basic EPS - Continuing Operations	38.26	35.74	-55.19	9.05	31.89
Basic Weighted Average Shares Outstanding	4.42M	4.42M	4.42M	4.42M	4.42M
Net EPS - Diluted	38.26	35.74	-55.19	9.05	31.89
Diluted EPS - Continuing Operations	38.26	35.74	-55.19	9.05	31.89
Diluted Weighted Average Shares Outstanding	4.42M	4.42M	4.42M	4.42M	4.42M
Normalized Basic EPS	49.23	27.14	11.17	9.19	29.41
Normalized Diluted EPS	49.23	27.14	11.17	9.19	29.41
Dividend Per Share	10	10	10	10	10
Payout Ratio	13.02	27.85	-18.03	110	31.21
Supplemental Items
EBITDA	588M	450M	416M	339M	417M
EBITA	312M	163M	64M	81M	205M
EBIT	312M	163M	64M	81M	205M
Effective Tax Rate - (Ratio)	33.46	19.8	30.29	38.46	38.16
Normalized Net Income	218M	120M	49.38M	40.62M	130M
Non-Cash Pension Expense	25.28M	28.59M	29.44M	29.44M	34.33M
Supplemental Operating Expense Items
Selling and Marketing Expenses	204M	187M	181M	197M	185M
General and Administrative Expenses	91M	49M	39M	39M	46M
Research And Development Expense From Footnotes	196M	169M	140M	4M	2M

Fiscal Period: March	2022 (JPY)	2023 (JPY)	2024 (JPY)	2025 (JPY)	2026 (JPY)
Assets
Cash And Equivalents	973M	780M	656M	467M	493M
Total Cash And Short Term Investments	973M	780M	656M	467M	493M
Accounts Receivable, Total	428M	463M	468M	482M	544M
Total Receivables	428M	463M	468M	482M	544M
Inventory	472M	498M	590M	540M	534M
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	47M	23M	23M	32M	47M
Total Current Assets	1.92B	1.76B	1.74B	1.52B	1.62B
Net Property Plant And Equipment	3.72B	3.68B	3.08B	2.88B	2.77B
Long-term Investments	5M	7M	6M	5M	105M
Other Intangibles, Total	106M	143M	117M	84M	52M
Deferred Tax Assets Long-Term	37M	45M	190M	195M	153M
Other Long-Term Assets, Total	2M	1M	1M	3M	1M
Total Assets	5.79B	5.64B	5.13B	4.69B	4.7B
Liabilities
Accounts Payable, Total	436M	412M	527M	343M	273M
Accrued Expenses, Total	52M	45M	54M	59M	72M
Short-term Borrowings	38M	193M	263M	350M	512M
Current Portion of Long-Term Debt	764M	671M	585M	663M	672M
Current Portion of Leases	25M	26M	15M	12M	12M
Current Income Taxes Payable	108M	106M	125M	103M	142M
Other Current Liabilities	75M	61M	70M	82M	59M
Total Current Liabilities	1.5B	1.51B	1.64B	1.61B	1.74B
Long-Term Debt	2.27B	2.02B	1.64B	1.29B	1.07B
Long-Term Leases	91M	65M	49M	37M	24M
Pension & Other Post Retirement Benefits	17M	19M	26M	27M	32M
Other Non Current Liabilities	12M	13M	13M	4M	4M
Total Liabilities	3.89B	3.63B	3.37B	2.97B	2.87B
Common Stock, Total	822M	822M	822M	822M	822M
Additional Paid In Capital	742M	742M	742M	742M	742M
Retained Earnings	366M	481M	192M	188M	285M
Treasury Stock	-7M	-8M	-8M	-8M	-8M
Comprehensive Income and Other	-21M	-23M	15M	-29M	-15M
Total Common Equity	1.9B	2.01B	1.76B	1.72B	1.83B
Total Equity	1.9B	2.01B	1.76B	1.72B	1.83B
Total Liabilities And Equity	5.79B	5.64B	5.13B	4.69B	4.7B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4.42M	4.42M	4.42M	4.42M	4.42M
ECS Total Common Shares Outstanding	4.42M	4.42M	4.42M	4.42M	4.42M
Book Value / Share	430.22	455.56	398.79	387.93	413.04
Tangible Book Value	1.8B	1.87B	1.65B	1.63B	1.77B
Tangible Book Value Per Share	406.25	423.21	372.32	368.93	401.28
Total Debt	3.19B	2.98B	2.55B	2.35B	2.29B
Net Debt	2.22B	2.2B	1.9B	1.89B	1.79B
Debt Equivalent of Unfunded Proj. Benefit Obligation	34.29M	38.93M	52.88M	54.95M	64.34M
Inventories - Raw Materials, Total	198M	266M	312M	263M	262M
Inventories - Work In Process, Total	30M	34M	67M	45M	43M
Inventories - Finished Goods, Total	243M	197M	211M	231M	228M
Inventories - Others	1M	1M	-	1M	1M
Full Time Employees	103	96	109	122	125
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	2M	2M
Order Backlog	81.31M	94.98M	234M	181M	187M

Fiscal Period: March	2022 (JPY)	2023 (JPY)	2024 (JPY)	2025 (JPY)	2026 (JPY)
Net Income	255M	198M	-350M	65M	229M
Depreciation & Amortization - CF	276M	287M	352M	258M	212M
Depreciation & Amortization, Total	276M	287M	352M	258M	212M
(Gain) Loss From Sale Of Asset	143M	4M	429M	-	-20M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Other Operating Activities, Total	128M	2M	-52M	-43M	-11M
Change In Accounts Receivable	89M	-33M	1M	-21M	-61M
Change In Inventories	-61M	-24M	-86M	44M	7M
Change In Accounts Payable	43M	-25M	119M	-154M	-92M
Change in Other Net Operating Assets	-73M	-48M	49M	-17M	9M
Cash from Operations	800M	361M	462M	132M	273M
Capital Expenditure	-445M	-229M	-155M	-65M	-56M
Sale of Property, Plant, and Equipment	1M	-	-	8M	23M
Sale (Purchase) of Intangible assets	-12M	-61M	-9M	-3M	-2M
Investment in Marketable and Equity Securities, Total	3M	-134M	-	-54M	-100M
Net (Increase) Decrease in Loans Originated / Sold - Investing	5M	-	-	-	-
Other Investing Activities, Total	27M	-2M	1M	-8M	-
Cash from Investing	-421M	-426M	-163M	-122M	-135M
Short Term Debt Issued, Total	-	150M	100M	100M	150M
Long-Term Debt Issued, Total	750M	550M	200M	350M	500M
Total Debt Issued	750M	700M	300M	450M	650M
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-901M	-894M	-667M	-619M	-715M
Total Debt Repaid	-901M	-894M	-667M	-619M	-715M
Issuance of Common Stock	18M	-	-	-	-
Common Dividends Paid	-22M	-44M	-44M	-44M	-44M
Common & Preferred Stock Dividends Paid	-22M	-44M	-44M	-44M	-44M
Other Financing Activities, Total	-24M	-25M	-26M	-16M	-12M
Cash from Financing	-179M	-263M	-437M	-229M	-121M
Foreign Exchange Rate Adjustments	2M	2M	14M	-7M	3M
Miscellaneous Cash Flow Adjustments	-1M	-	-	-1M	-
Net Change in Cash	201M	-326M	-124M	-227M	20M
Supplemental Items
Cash Interest Paid	17M	15M	13M	14M	18M
Cash Income Tax Paid (Refund)	25M	47M	57M	42M	15M
Levered Free Cash Flow	152M	5.5M	275M	69.88M	159M
Unlevered Free Cash Flow	163M	14.88M	283M	78.62M	170M
Change In Net Working Capital	-149M	84M	-55M	162M	112M
Net Debt Issued / Repaid	-151M	-194M	-367M	-169M	-65M

Fiscal Period: March	2022 (JPY)	2023 (JPY)	2024 (JPY)	2025 (JPY)	2026 (JPY)
Profitability
Return on Assets	3.38	1.78	0.74	1.03	2.73
Return on Total Capital	3.82	2.02	0.86	1.21	3.13
Return On Equity %	9.33	8.07	-12.92	2.3	7.96
Return on Common Equity	9.33	8.07	-12.92	2.3	7.96
Margin Analysis
Gross Profit Margin %	51.07	46.27	43.37	40.24	39.68
SG&A Margin	34.22	34.62	36.94	37.55	33.51
EBITDA Margin %	19.05	15.2	13.1	10.59	12.42
EBITA Margin %	10.11	5.5	2.02	2.53	6.11
EBIT Margin %	10.11	5.5	2.02	2.53	6.11
Income From Continuing Operations Margin %	5.48	5.34	-7.68	1.25	4.2
Net Income Margin %	5.48	5.34	-7.68	1.25	4.2
Net Avail. For Common Margin %	5.48	5.34	-7.68	1.25	4.2
Normalized Net Income Margin	7.05	4.05	1.56	1.27	3.87
Levered Free Cash Flow Margin	4.94	0.19	8.66	2.18	4.73
Unlevered Free Cash Flow Margin	5.28	0.5	8.91	2.46	5.07
Asset Turnover
Asset Turnover	0.54	0.52	0.59	0.65	0.72
Fixed Assets Turnover	0.83	0.8	0.94	1.07	1.19
Receivables Turnover (Average Receivables)	6.6	6.65	6.82	6.74	6.54
Inventory Turnover (Average Inventory)	3.43	3.28	3.31	3.39	3.77
Short Term Liquidity
Current Ratio	1.28	1.17	1.06	0.94	0.93
Quick Ratio	0.94	0.82	0.69	0.59	0.6
Operating Cash Flow to Current Liabilities	0.53	0.24	0.28	0.08	0.16
Days Sales Outstanding (Average Receivables)	55.29	54.92	53.66	54.16	55.78
Days Outstanding Inventory (Average Inventory)	106.36	111.27	110.74	107.8	96.79
Average Days Payable Outstanding	94.73	95.71	90.92	85.23	55.68
Cash Conversion Cycle (Average Days)	66.92	70.47	73.48	76.74	96.89
Long Term Solvency
Total Debt/Equity	167.67	147.72	144.7	137.2	125.25
Total Debt / Total Capital	62.64	59.63	59.13	57.84	55.6
LT Debt/Equity	124.18	103.53	95.75	77.43	59.75
Long-Term Debt / Total Capital	46.4	41.79	39.13	32.64	26.53
Total Liabilities / Total Assets	67.16	64.32	65.63	63.4	61.11
EBIT / Interest Expense	18.35	10.87	4.92	5.79	11.39
EBITDA / Interest Expense	34.59	30	32	24.21	23.17
(EBITDA - Capex) / Interest Expense	8.41	14.73	20.08	19.57	20.06
Total Debt / EBITDA	5.42	6.61	6.13	6.94	5.48
Net Debt / EBITDA	3.77	4.88	4.56	5.56	4.3
Total Debt / (EBITDA - Capex)	22.3	13.46	9.77	8.59	6.34
Net Debt / (EBITDA - Capex)	15.5	9.93	7.26	6.88	4.97
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	8.09	-4.05	7.23	0.82	4.87
Gross Profit, 1 Yr. Growth %	18.94	-13.07	0.51	-6.46	3.42
EBITDA, 1 Yr. Growth %	25.91	-23.47	-7.56	-18.51	23.01
EBITA, 1 Yr. Growth %	122.86	-47.76	-60.74	26.56	153.09
EBIT, 1 Yr. Growth %	122.86	-47.76	-60.74	26.56	153.09
Earnings From Cont. Operations, 1 Yr. Growth %	125.33	-6.51	-254.43	-116.39	252.5
Net Income, 1 Yr. Growth %	125.33	-6.51	-254.43	-116.39	252.5
Normalized Net Income, 1 Yr. Growth %	84.13	-44.83	-58.85	-17.72	220
Diluted EPS Before Extra, 1 Yr. Growth %	124.45	-6.58	-254.43	-116.39	252.51
Accounts Receivable, 1 Yr. Growth %	-15.58	8.18	1.08	2.99	12.86
Inventory, 1 Yr. Growth %	15.69	5.51	18.47	-8.47	-1.11
Net Property, Plant and Equip., 1 Yr. Growth %	0.24	-0.97	-16.47	-6.5	-3.89
Total Assets, 1 Yr. Growth %	0.84	-2.52	-9.14	-8.64	0.19
Tangible Book Value, 1 Yr. Growth %	11.9	4.18	-12.03	-0.91	8.77
Common Equity, 1 Yr. Growth %	10.52	5.89	-12.46	-2.72	6.47
Cash From Operations, 1 Yr. Growth %	75.05	-54.88	27.98	-71.43	106.82
Capital Expenditures, 1 Yr. Growth %	22.93	-48.54	-32.31	-58.06	-13.85
Levered Free Cash Flow, 1 Yr. Growth %	-419.11	-96.39	4.9K	-74.58	127.37
Unlevered Free Cash Flow, 1 Yr. Growth %	-546.58	-90.87	1.8K	-72.22	116.38
Dividend Per Share, 1 Yr. Growth %	100	0	0	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	1.81	1.84	1.43	3.97	2.83
Gross Profit, 2 Yr. CAGR %	4.98	1.68	-6.53	-3.04	-1.65
EBITDA, 2 Yr. CAGR %	7.91	-1.84	-15.89	-13.21	0.12
EBITA, 2 Yr. CAGR %	54.92	7.9	-54.71	-29.51	78.97
EBIT, 2 Yr. CAGR %	54.92	7.9	-54.71	-29.51	78.97
Earnings From Cont. Operations, 2 Yr. CAGR %	110.89	45.14	20.16	-49.68	-23.98
Net Income, 2 Yr. CAGR %	110.89	45.14	20.16	-49.68	-23.98
Normalized Net Income, 2 Yr. CAGR %	66.19	0.79	-52.35	-41.82	62.26
Diluted EPS Before Extra, 2 Yr. CAGR %	110.12	44.8	20.11	-49.68	-23.98
Accounts Receivable, 2 Yr. CAGR %	0.71	-4.44	4.57	2.03	7.81
Inventory, 2 Yr. CAGR %	2.3	10.48	11.8	4.13	-4.86
Net Property, Plant and Equip., 2 Yr. CAGR %	0.84	-0.36	-9.05	-11.63	-5.2
Total Assets, 2 Yr. CAGR %	4.16	-0.86	-5.89	-8.89	-4.32
Tangible Book Value, 2 Yr. CAGR %	8.17	7.97	-4.27	-6.63	3.82
Common Equity, 2 Yr. CAGR %	8.12	8.18	-3.72	-7.72	1.77
Cash From Operations, 2 Yr. CAGR %	42.31	-11.12	-24.01	-39.53	-23.13
Capital Expenditures, 2 Yr. CAGR %	17.38	-20.46	-40.98	-46.72	-39.89
Levered Free Cash Flow, 2 Yr. CAGR %	420.47	-66.06	34.31	256.43	-23.97
Unlevered Free Cash Flow, 2 Yr. CAGR %	216.71	-36.16	31.76	129.91	-22.47
Dividend Per Share, 2 Yr. CAGR %	82.57	41.42	0	0	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.46	-0.18	3.6	1.23	4.27
Gross Profit, 3 Yr. CAGR %	4.75	-1.42	1.29	-6.51	-0.93
EBITDA, 3 Yr. CAGR %	3.07	-3.77	-3.78	-16.77	-2.51
EBITA, 3 Yr. CAGR %	14.47	7.83	-22.97	-36.21	7.94
EBIT, 3 Yr. CAGR %	14.47	7.83	-22.97	-36.21	7.94
Earnings From Cont. Operations, 3 Yr. CAGR %	9.99	60.8	48.18	-38.14	-3.72
Net Income, 3 Yr. CAGR %	9.99	60.8	48.18	-38.14	-3.72
Normalized Net Income, 3 Yr. CAGR %	21.5	15.07	-25.23	-42.84	2.7
Diluted EPS Before Extra, 3 Yr. CAGR %	9.94	60.37	47.95	-38.16	-3.72
Accounts Receivable, 3 Yr. CAGR %	-1.73	3.14	-2.63	4.04	5.52
Inventory, 3 Yr. CAGR %	6.21	3.36	13.08	4.59	2.35
Net Property, Plant and Equip., 3 Yr. CAGR %	-0.76	0.24	-6.05	-8.21	-9.12
Total Assets, 3 Yr. CAGR %	2.6	1.88	-3.7	-6.81	-5.96
Tangible Book Value, 3 Yr. CAGR %	4.3	6.82	0.84	-3.16	-1.76
Common Equity, 3 Yr. CAGR %	4.52	7.37	0.81	-3.39	-3.21
Cash From Operations, 3 Yr. CAGR %	9.7	-2.96	0.36	-45.15	-8.89
Capital Expenditures, 3 Yr. CAGR %	-10.03	-10.83	-24.63	-47.34	-37.47
Levered Free Cash Flow, 3 Yr. CAGR %	4.05	-0.75	79.22	-22.89	206.83
Unlevered Free Cash Flow, 3 Yr. CAGR %	9.54	-2.9	97.92	-21.57	125.3
Dividend Per Share, 3 Yr. CAGR %	0	49.38	25.99	0	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.44	2.1	1.45	1.46	3.29
Gross Profit, 5 Yr. CAGR %	5.34	1.19	0.09	-2.07	0.11
EBITDA, 5 Yr. CAGR %	6.96	1.25	-4.98	-7.66	-2.24
EBITA, 5 Yr. CAGR %	12.91	2.8	-21	-9.03	7.93
EBIT, 5 Yr. CAGR %	12.91	2.8	-21	-9.03	7.93
Earnings From Cont. Operations, 5 Yr. CAGR %	27.08	14.02	13.95	1.03	13.46
Net Income, 5 Yr. CAGR %	27.08	14.02	13.95	1.03	13.46
Normalized Net Income, 5 Yr. CAGR %	20.5	12.2	-16.45	-12.4	1.93
Diluted EPS Before Extra, 5 Yr. CAGR %	26.52	13.78	13.9	0.87	13.35
Accounts Receivable, 5 Yr. CAGR %	1.01	3.12	0.74	2.69	1.42
Inventory, 5 Yr. CAGR %	5.74	3.17	8.41	3.67	5.53
Net Property, Plant and Equip., 5 Yr. CAGR %	-1.47	-1.01	-4.16	-4.69	-5.71
Total Assets, 5 Yr. CAGR %	0.71	-0.8	-0.88	-2.57	-3.95
Tangible Book Value, 5 Yr. CAGR %	5.35	5.14	0.78	1.22	2.02
Common Equity, 5 Yr. CAGR %	4.96	5.3	1.14	1.06	1.19
Cash From Operations, 5 Yr. CAGR %	31.17	2.7	-5.28	-19.69	-9.79
Capital Expenditures, 5 Yr. CAGR %	-26.09	-26.48	-23.99	-27.43	-31.15
Levered Free Cash Flow, 5 Yr. CAGR %	-39.01	-62.56	15.24	65.52	27.18
Unlevered Free Cash Flow, 5 Yr. CAGR %	-38.11	-54.16	17.94	37.07	36.05
Dividend Per Share, 5 Yr. CAGR %	0	0	0	27.23	14.87